Velardi, Enrico http://orcid.org/0000-0001-8383-0453
Tsai, Jennifer J. http://orcid.org/0000-0002-9267-4584
van den Brink, Marcel R. M. http://orcid.org/0000-0003-0696-4401
Article History
Accepted: 23 September 2020
First Online: 23 October 2020
Competing interests
: M.R.M.v.d.B. has received research support and stock options from Seres Therapeutics, has received royalties from Wolters Kluwer, has consulted for, received honoraria from or participated in advisory boards for Seres Therapeutics, Jazz Pharmaceuticals, Rheos, Therakos, WindMIL Therapeutics, Amgen, Merck & Co. Inc., Magenta Therapeutics, DKMS Medical Council (board), Forty Seven Inc. (spouse), Pharmacyclics (spouse) and Kite Pharmaceuticals (spouse) and has intellectual property licensing agreements with Seres Therapeutics and Juno Therapeutics. E.V. has acted as a consultant for and received honoraria from Ferring Pharmaceuticals. M.R.M.v.d.B. is an inventor on a patent application (US2015/058095) submitted by Memorial Sloan Kettering Cancer Center. Two provisional patent applications have been filed (US 15/033,178 and US 62/566,897) with E.V. and M.R.M.v.d.B. listed as inventors. J.J.T. declares no competing interests.
Free to read: This content has been made available to all.